• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES DR VAMP VENOUS ARTERIAL BLOOD MANAGEMENT PROTECTION SYSTEM; KIT, SAMPLING, ARTERIAL BLOOD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES DR VAMP VENOUS ARTERIAL BLOOD MANAGEMENT PROTECTION SYSTEM; KIT, SAMPLING, ARTERIAL BLOOD Back to Search Results
Model Number 48VMP106
Device Problems Fluid/Blood Leak (1250); Leak/Splash (1354)
Patient Problems No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692)
Event Date 04/02/2019
Event Type  malfunction  
Manufacturer Narrative
The device evaluation is anticipated.However the complaint cannot not be confirmed without the completion of a product evaluation.A supplemental report will be forthcoming with the evaluation and device history results when received.
 
Event Description
As reported, during use in a (b)(6) year old male patient, in this vamp adult system, serum and blood leakage in the ¿rubber path¿, (leakage at the plunger seal), was observed.The device was exchanged for a new one and worked successfully.There was no allegation of patient injury.The vamp system was available for evaluation.
 
Manufacturer Narrative
One vamp adult system was returned for examination.The reported event of "blood leakage in the rubber path" was confirmed.As received dry blood was evident on the plunger side of the blue seal and on the inside of the contamination shield.Blood residues were evident between the seal and the reservoir.It was apparent that blood had leaked past the blue seal to the plunger side and out of the reservoir cap into contamination shield.A simulated use test was performed to the vamp system in attempt to recreate how blood passed the seal into plunger side.But no leakage was detected past the seal during simulated use test if the ifu recommendations were followed.The ifu recommends to smoothly and evenly move the plunger at rate of 5ml per 3-5 seconds during aspiration and injection of blood from the reservoir.A review of the manufacturing records indicated that the product met specifications upon release.An investigation has been initiated to consider any potential manufacturing factors that may have contributed to this complaint and implement any necessary corrective actions.Invasive procedures involve some patient risks.Although serious complications are relatively uncommon, the physician is advised to consider the potential benefits in relation to the possible complications.It is common clinical practice to inspect all products before use.These products are used by highly trained clinicians, experienced in identifying and mitigating any hazards that arise during use.In addition, these devices are typically used in intensive care units or operating rooms, where patients are closely monitored.In this case, there were no patient complications noted.A complaint of blood past the plunger seal can be due to a manufacturing non-conformance or user technique.In this instance evaluation lab testing demonstrated that the device worked correctly when properly used.It is possible that user or procedural factors contributed to the event.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Manufacturer Narrative
Please see manufacturing and expiration date associated with the lot number.
 
Manufacturer Narrative
The investigation of this vamp adult system concluded that a potential root cause of blood leaking past the blue seal could be related to an incorrect solvent bonding execution during the assembly process and/or the malpositioning of the seal in the plunger.Personnel notification was performed.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VAMP VENOUS ARTERIAL BLOOD MANAGEMENT PROTECTION SYSTEM
Type of Device
KIT, SAMPLING, ARTERIAL BLOOD
Manufacturer (Section D)
EDWARDS LIFESCIENCES DR
parque industrial de itabo
carr. sanchez km 18.5
haina, san cristobal
DR 
MDR Report Key8542024
MDR Text Key143436863
Report Number2015691-2019-01425
Device Sequence Number1
Product Code CBT
Combination Product (y/n)N
PMA/PMN Number
CLASS I EXEM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 04/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/23/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/13/2020
Device Model Number48VMP106
Device Lot Number61533061
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/13/2019
Date Manufacturer Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-